Publications by authors named "Komal Qayyum"
Ann Med Surg (Lond)
July 2024
Article Synopsis
- Hospitalized COVID-19 patients face a high risk of thromboembolism and death, creating a need to compare the safety and effectiveness of factor Xa inhibitors versus enoxaparin for prevention.
- A systematic review of studies revealed 4048 patients, showing that factor Xa inhibitors reduced thromboembolism incidence compared to enoxaparin, but results varied significantly by study type.
- The analysis concluded that while factor Xa inhibitors appear more effective in preventing thromboembolism later than during acute illness, there was no significant difference in bleeding or overall mortality rates between the two medications.
